SVRA Savara Inc

$SVRA the response to the JP Morgan 12 dollar PT to me indicates that the some people need a little reassurance. and the past recent behaviour is nothing but nervousness

$SVRA the strongest stocks are getting caught up in the sell off . We will need a day of capitulation hopefully in the next couple of weeks, I would not be a buyer of the stock until I see a confirmation of a capitulation. The fundamentals of the stock/company seem to be intact. It’s reassuring that JP Morgan recently came out with a $12 stock price. Hang in there guys it’s gonna be a rough a few weeks!

$SVRA 1.5-3B/yr opportunity from US, EU, Japan. Approval is a foregone conclusion. Even 1B year from these 3 areas is enough for 3B valuation. US approval Nov, EU 1h 2027. Stupid cheap.

$SVRA just junk at low volume to induce retail panic selling so people can clean up shares at low prices, hold the fort, there’s no reason the price is dropping outside of that manipulation

$SVRA Q2 hedges loaded up super heavy. Q3 silence … I’ll gladly take $17$-20 for my shares. However if it fails it could easily head bad to $1 IMO. I owned this at $11 then a failure. Bain came in and it went from $.90 to $1.50 then $3.50 before settling. This PDUFA has been long awaited…The suspense is driving me nuts!

$SVRA I have been here along time and based on their track record and history of the company, they have been unable to get this over the finish line, I think the market is now understanding they won't be able too. That is why so many shorts. Just tough to watch. A lot more people in the know than us. SVRA reputation for execution has been terrible, I am praying they get this done.

$SVRA sitting near strong support. Looking for a run back up to the resistance at around 6.60

$SVRA With the crazy amount of shorts in this I am surprised that reddit hasn't created a squeeze like $GME lol. The amount of shorts is incredible

$SVRA adding. With pending PDUFA and first approved therapy for aPAP, company will have a MOAT. Still consider it a good BO candidate.

$SVRA with pending PDUFA may be worth a re-entry. Still see this as a good BO candidate.

$SVRA If I take a step back and look at the real situation. The company has very good and positive studies, which I in my opinion should get through the FDA. There’s a clear need for this medication. It is likely the stock is caught up in the macro environment. There has been no significant Block selling from what I can see. It is just fear in my opinion. The price of the stock is unjustified and should move higher.

$SVRA is this the beginning of a really good Story? If we see a good day today it might be that we have been at the bottom! Let‘s watch closely!

📅 CATALYST REMINDER | $SVRA October 20–21, 2026 — Clinical Data Presentations Molgramostim long-term efficacy and safety analyses from IMPALA-2 will be presented at CHEST 2026; not a new pivotal readout. More details in our hub. #SVRA #Biotech #CHEST2026

$SVRA Very interesting. A single asset to treat an ultra rare disease (10 in a million) From humanity point of view this offers great hope but from commercial view it would be an interesting to see how cash needed to run/maintain and how much cash will this generate I hold no position. Just tracking since june 2026

$SVRA Something is very wrong here. If the stock is being manipulated, I would think that they would want to buy an unload prior to the third week of November great. What is concerning is apparently they canceled two press conferences. I may be wrong on that.